This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Luminex Corporation Participates In Community Initiatives To Save Lives

Stocks in this article: LMNX

AUSTIN, Texas, Oct. 1, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that they have joined forces again this year with the National Marrow Donor Program – Be The Match® to raise awareness of the need for additional bone marrow donors to help save lives. In addition to sponsoring the 18th Annual Marrow Ambassadors Golf Tournament, Luminex will be conducting a donor drive at the event, which will be held at Twin Creeks Country Club in Cedar Park, Texas.  

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

Every year, thousands of people of all ages are diagnosed with blood cancers like leukemia or lymphoma, sickle cell anemia or other life-threatening diseases.  Many of them will die unless they get a bone marrow or cord blood transplant from a matching donor.  However, medical advances are making marrow and umbilical cord blood transplants available to more patients all the time.  Since beginning operations in 1987, the Be The Match® registry has grown to more than 10 million donors, and has facilitated over 50,000 transplants.  Today, more than 5,500 transplants are facilitated a year. 

Laboratories around the world currently use Luminex xMAP® Technology to match donors and transplant recipients, and to monitor post-transplant rejection.  Human Leukocyte Antigens (HLA) found in the blood, are the primary source of immuno-rejection during transplant. This class of markers is characterized by numerous genetic mutations, many of which directly affect the immune response during transplantation. Luminex xMAP® Technology allows high-resolution genotyping of up to 100 unique alleles within a single sample volume prior to a patient undergoing transplant surgery. The same xMAP platform can then be used to perform immunoassays that test for an antibody response in the patient post-surgery.

"We are honored to support the efforts of the Marrow Ambassadors and the National Marrow Donor Program – Be The Match® and to help raise awareness of the need for additional donors," said Patrick J. Balthrop, president and CEO of Luminex. "It is inspiring to all of us at Luminex to personally meet members of our community that have been brought together through our technology, and it reinforces our mission of innovating solutions that save lives."

At this year's event, donor Zach Moore, a college student who joined the registry through his university, will meet with the recipient of his marrow transplant, Shannon Dean Turci, a 38-year-old mother diagnosed with Acute Myeloid Leukemia, now in remission. Also in attendance will be participants from Seton Hospital [and Central Health], as well as community members leading efforts to create a medical school here in Austin. 

Luminex, a leader in the Austin biotechnology community, is a strong supporter of the medical school initiative, which has significant potential to foster further growth of the biotechnology industry, and continue innovation of life-saving technologies for patients worldwide.  Sandy Guzman, Legislative Director to Texas State Senator Kirk Watson, will provide further insight about the initiative during the dinner program. 

About the Marrow Ambassadors Golf Tournament

The 18th Annual Marrow Ambassadors Golf Tournament benefits the Marrow Donor Programs of Central and South Texas by providing tissue-typing funds for donors, and by making matches possible for patients in need of life-saving bone marrow transplants.  Since 1994, Founder Steele Zinser and the Bone Marrow Ambassadors have raised funds for hundreds of Central Texas donors through this annual event. 

To register for the golf tournament, visit http://www.southtexasblood.org/BeTheMatch.asp.   For additional information about joining the donor registry, and helping to save a life, visit http://www.marrow.org/Join/Join_the_Registry.aspx  or call Aracely Calzadias, Marrow Recruitment Consultant for the National Marrow Donor Program – Be The Match in Austin at (512) 206-1331.

About Luminex Corporation

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform, MultiCode® real-time polymerase chain reaction (PCR), and multiplex PCR-based technologies, that deliver cost-effective rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories, as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. Luminex is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, biodefense research and food safety.  For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit  http://www.luminexcorp.com/.

Contact:   Investors:   Matt Scalo  Luminex Corporation  mscalo@luminexcorp.com  512.336.3587

Media:   Mimi Torrington                                                      Luminex Corporation                                             mtorrington@luminexcorp.com            512.219.8020                                                          

Aaron DeLucia                                                        Porter Novelli                                                          aaron.delucia@porternovelli.com                                                        512.241.2249 

SOURCE Luminex Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,062.57 +8.86 0.05%
S&P 500 2,093.16 +4.39 0.21%
NASDAQ 4,809.2020 +2.3430 0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs